174 related articles for article (PubMed ID: 36777384)
1. Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study.
de Siqueira GSM; Hanna SA; de Moura LF; Miranda FA; Carvalho HA; Marta GN
Lancet Reg Health Am; 2022 Oct; 14():100323. PubMed ID: 36777384
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
De Matteis S; Facondo G; Valeriani M; Vullo G; De Sanctis V; Ascolese AM; Campanella B; Scalabrino G; Osti MF
Clin Breast Cancer; 2022 Apr; 22(3):e332-e340. PubMed ID: 34670727
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
Bellefqih S; Elmajjaoui S; Aarab J; Khalil J; Afif M; Lachgar A; El Kacemi H; Kebdani T; Benjaafar N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):563-570. PubMed ID: 28126305
[TBL] [Abstract][Full Text] [Related]
4. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
Fodor A; Brombin C; Mangili P; Borroni F; Pasetti M; Tummineri R; Zerbetto F; Longobardi B; Perna L; Dell'Oca I; Deantoni CL; Deli AM; Chiara A; Broggi S; Castriconi R; Esposito PG; Slim N; Passoni P; Baroni S; Villa SL; Rancoita PMV; Fiorino C; Del Vecchio A; Bianchini G; Gentilini OD; Di Serio MS; Di Muzio NG
Breast; 2021 Feb; 55():45-54. PubMed ID: 33326894
[TBL] [Abstract][Full Text] [Related]
5. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
[TBL] [Abstract][Full Text] [Related]
6. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
Reshko LB; Pan J; Rai SN; Ajkay N; Dragun A; Roberts TL; Riley EC; Quillo AR; Scoggins CR; McMasters KM; Eldredge-Hindy H
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):56-65. PubMed ID: 34710520
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated course of radiotherapy (RT) for breast cancer.
Schoenfeld JD; Harris JR
Breast; 2011 Oct; 20 Suppl 3():S116-27. PubMed ID: 22015277
[TBL] [Abstract][Full Text] [Related]
8. Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer.
Jain N; Sharma R; Sachdeva K; Kaur A; Sudan M
J Med Phys; 2022; 47(2):141-144. PubMed ID: 36212213
[TBL] [Abstract][Full Text] [Related]
9. Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean.
Marta GN; Moraes FY; de Oliveira Franco RC; de Andrade Carvalho H; Gouveia AG; de Lima Gössling GC; de Jesus RG; Ferraris G; Schuffenegger PM; Bardales GS; Chacón MAP; Murillo R; Sánchez LEM; Gamarra-Cabezas E; Rosa AA; da Silva MF; de Mattos MD; Morais DCR; de Castro DG; Dal Pra A; Amêndola BE; Barros JM; Lara TM; Isa N; de la Mata Moya D; Hidalgo I; Velilla DG; Loayza LEA; Montenegro FG; Sanchez Chacin NO; Werutsky G; Viani GA
Rep Pract Oncol Radiother; 2023; 28(3):340-351. PubMed ID: 37795395
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
12. First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.
Dragun AE; Ajkay NJ; Riley EC; Roberts TL; Pan J; Rai SN; Jain D; Quillo AR; Scoggins CR; McMasters KM; Woo SY
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):595-602. PubMed ID: 28581400
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
[TBL] [Abstract][Full Text] [Related]
15. Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials.
Marta GN; Riera R; Pacheco RL; Cabrera Martimbianco AL; Meattini I; Kaidar-Person O; Poortmans P
Breast; 2022 Apr; 62():84-92. PubMed ID: 35131647
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
[TBL] [Abstract][Full Text] [Related]
17. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiotherapy after breast-conserving surgery: Clinical and dosimetric factors predictive of acute skin toxicity.
Ben Amor R; Bohli M; Naimi Z; Aissaoui D; Mejri N; Yahyaoui J; Hamdoun A; Kochbati L
Strahlenther Onkol; 2023 Jan; 199(1):48-54. PubMed ID: 35943552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
